PRESTIGE CONSUMER HEALTHCARE INC.

Analyst Reco. Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Market Closed - Nyse Other stock markets 21:00:01 26/04/2024 BST			5-day change	1st Jan Change
70.47 ^USD	+0.47%		+1.15%	+15.11%

02-16	Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing	MT
02-16	Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating	17/02/23	MT
Canaccord Genuity Starts Prestige Consumer Healthcare at Buy With $71 Price Target	17/11/22	MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $63 From $68, Maintains Outperform Rating	27/09/22	MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maintains Outperform Rating	01/08/22	MT
ANALYST RECOMMENDATIONS : Edison International, Ford, General Motors, GSK, Upstart...	10/05/22
Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65	10/05/22	MT
DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating	09/05/22	MT
Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target	09/05/22	MT
DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating	15/11/21	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $61 from $52, Keeps Neutral Rating	06/08/21	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $52 from $49, Keeps Neutral Rating	28/05/21	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $49 from $39, Keeps Neutral Rating	10/05/21	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $45, Maintains Neutral Rating	06/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer